Vanguard Personalized Indexing Management, LLC Krystal Biotech, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 1,695 shares of KRYS stock, worth $332,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,695
Previous 1,946
12.9%
Holding current value
$332,152
Previous $350,000
33.71%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding KRYS
# of Institutions
315Shares Held
24.7MCall Options Held
418KPut Options Held
485K-
Black Rock Inc. New York, NY3.95MShares$774 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$553 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.66MShares$521 Million6.67% of portfolio
-
State Street Corp Boston, MA1.36MShares$266 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA942KShares$185 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $5.03B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...